DocGo Inc (DCGO)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $20.55M
Last updated: Nov 17, 2026 at 11:02 AM ET
DocGo Inc (DCGO) Earnings: Report Dates and Results
DocGo (DCGO) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, DocGo reported EPS of -$0.17, below the -$0.04 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DCGO has an expected report date of Mar 15, 2027.
DCGO Earnings Call
The latest DCGO earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 18 quarters below that had an estimate, DCGO beat 7 and missed 11. Revenue for the quarter ended Sep 30, 2026 was $73.43M, up 3.7% from $70.81M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.17 | -$0.04 | -$0.15 - -$0.02 | -325.00% | Miss | N/A | 2 | 0 up, 1 down | Nov 9, 2026 | $73.43M |
| Jun 30, 2026 | $0.16 | -$0.04 | N/A | +500.00% | Beat | N/A | 2 | 0 up, 0 down | Aug 17, 2026 | $73.42M |
| Mar 31, 2026 | -$0.33 | -$0.06 | -$0.22 - $0.10 | -450.00% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2026 | $75.55M |
| Dec 31, 2025 | -$1.68 | -$0.14 | N/A | N/A | N/A | -3511.4% | 2 | 0 up, 0 down | Mar 16, 2026 | $74.94M |
| Sep 30, 2025 | -$0.25 | -$0.40 | -$0.40 - -$0.40 | +37.50% | Beat | -200.0% | 1 | 0 up, 1 down | Nov 10, 2025 | $70.81M |
| Jun 30, 2025 | -$0.11 | -$0.06 | N/A | -83.33% | Miss | -137.9% | 2 | 0 up, 1 down | Aug 7, 2025 | $80.42M |
| Mar 31, 2025 | -$0.17 | $0.03 | -$0.07 - $0.14 | -666.67% | Miss | -136.2% | 2 | 0 up, 1 down | May 8, 2025 | $96.03M |
| Dec 31, 2024 | $0.05 | $0.21 | $0.11 - $0.26 | -76.60% | Miss | -29.7% | 3 | 0 up, 2 down | Feb 27, 2025 | $120.83M |
| Sep 30, 2024 | $0.25 | $0.24 | N/A | +4.17% | Beat | +8.7% | 7 | 0 up, 0 down | Nov 7, 2024 | $138.68M |
| Jun 30, 2024 | $0.29 | $0.35 | N/A | -17.14% | Miss | +383.3% | 6 | 0 up, 0 down | Aug 7, 2024 | $164.95M |
| Mar 31, 2024 | $0.47 | $0.34 | N/A | +38.24% | Beat | +487.5% | 7 | 0 up, 1 down | May 8, 2024 | $192.09M |
| Dec 31, 2023 | $0.07 | $0.10 | $0.07 - $0.13 | -30.00% | Miss | +600.0% | 7 | 0 up, 0 down | Feb 28, 2024 | $199.25M |
| Sep 30, 2023 | $0.23 | $0.21 | N/A | +9.52% | Beat | +91.7% | 6 | 0 up, 0 down | Nov 6, 2023 | $186.55M |
| Jun 30, 2023 | $0.06 | $0.14 | N/A | -57.14% | Miss | -87.8% | 6 | 0 up, 1 down | Aug 7, 2023 | $125.49M |
| Mar 31, 2023 | $0.08 | $0.09 | N/A | -11.11% | Miss | -78.9% | 6 | 0 up, 0 down | May 8, 2023 | $113.00M |
| Dec 31, 2022 | $0.01 | $0.05 | $0.03 - $0.06 | -80.00% | Miss | -95.7% | 5 | 0 up, 0 down | Mar 13, 2023 | $108.78M |
| Sep 30, 2022 | $0.12 | $0.17 | N/A | -29.41% | Miss | -99.9% | 6 | 0 up, 0 down | Nov 7, 2022 | $104.32M |
| Jun 30, 2022 | $0.49 | $0.13 | N/A | +276.92% | Beat | N/A | 6 | 0 up, 0 down | Aug 8, 2022 | $109.52M |
| Mar 31, 2022 | $0.38 | $0.19 | N/A | +100.00% | Beat | +171.4% | 4 | 0 up, 0 down | May 9, 2022 | $117.89M |
| Dec 31, 2021 | $0.23 | $0.02 | $0.01 - $0.03 | N/A | N/A | N/A | 4 | 0 up, 0 down | Mar 14, 2022 | $121.00M |
| Sep 30, 2021 | $99.28 | $0.03 | N/A | N/A | N/A | N/A | 1 | 1 up, 0 down | Nov 15, 2021 | $85.84M |
| Jun 30, 2021 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2021 | $62.19M |
| Mar 31, 2021 | $0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 3, 2021 | $49.69M |
| Dec 31, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2021 | $31.24M |
| Sep 30, 2020 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Nov 25, 2020 | $26.94M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.21, after $1.06 the year before. It was -$0.01 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.21 | -308.5% |
| Dec 31, 2024 | $1.06 | +140.7% |
| Dec 31, 2023 | $0.44 | -56.0% |
| Dec 31, 2022 | $1.00 | -99.0% |
| Dec 31, 2021 | $99.61 | N/A |
| Dec 31, 2020 | -$0.01 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,900 words across 9 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,919 | 9 | |
| 2026Q2 | Jun 30, 2026 | 7,075 | 7 | |
| 2026Q1 | Mar 31, 2026 | 6,258 | 8 | |
| 2025Q4 | Dec 31, 2025 | 8,143 | 9 | |
| 2025Q3 | Sep 30, 2025 | 6,948 | 9 | |
| 2025Q2 | Jun 30, 2025 | 4,236 | 6 | |
| 2025Q1 | Mar 31, 2025 | 7,165 | 8 | |
| 2024Q4 | Dec 31, 2024 | 9,757 | 9 |
2026Q3 Earnings Call
Opening remarks
Mike Cole Vice President, Investor Relations Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements made in this conference call other than statements of historical fact are forward-looking statements. The words may, will, plan, potential, could, goal, outlook, design, anticipate, aim, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions may be used to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance, and we cannot assure you that we will achieve or realize our plans, intentions, outcomes, results, or expectations. Forward-looking statements are inherently subject to substantial risks, uncertainties, and assumptions, many of which are beyond our control and which may cause our actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in our forward-looking statements. These risks, uncertainties, and assumptions include, but are not limited to, those discussed in risk factors and elsewhere in DocGo's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release for this quarter, and other reports and statements filed by DocGo with the SEC, to which your attention is directed. Actual outcomes and results, or the timing of results or outcomes, may differ materially from what is expressed or implied by these forward-looking statements. In addition, today's call contains references to non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in our earnings release and the current report on Form 8-K that includes our earnings release, which is posted on our website, docgo.com, as well as filed with the SEC. The information contained in this call is accurate as of only the date discussed. Investors should not assume that statements will remain relevant and operative at a later time. We undertake no obligation to update any information discussed in this call to reflect events or circumstances after the date of this call, or to reflect new information or the occurrence of unanticipated events, except to the extent required by law. At this time, it is now my pleasure to turn the call over to Mr. Lee Bienstock, CEO of DocGo. Lee, please go ahead.
Lee Bienstock CEO Thank you, Mike, and thank you all for joining us. We have a lot to cover on today's call. First, Norm and I will dive into the operational details, and then I'll discuss the CEO transition. Today, I'm pleased to report considerable progress on our path toward profitability.
Frequently Asked Questions About DCGO
When is DocGo's next earnings date?
DocGo's next earnings report is expected for Mar 15, 2027.
Did DCGO beat earnings estimates last quarter?
No. DocGo reported EPS of -$0.17 for the quarter ended Sep 30, 2026, below the -$0.04 estimate by 325.00%.
What EPS do analysts expect from DCGO next quarter?
The consensus EPS estimate for DocGo for the quarter ending Dec 31, 2026 is -$0.07 from 7 analysts, with estimates from -$0.08 to -$0.06.
How often does DCGO beat earnings estimates?
DocGo beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -132.49%.
DCGO pages: Overview, Earnings, Forecast, Financials, Competitors